ReleaseWire Connect

In recognition of April's Alcohol Awareness Month, Sovereign Health Group will offer extensive editorial coverage throughout the month. Founded by the National Council on Alcoholism and Drug Dependence, Inc. (NCADD) in 1987, the goal of Alcohol Awareness Month is to help raise public awareness about alcoholism and encourage communities to take action to stem the tide of alcohol abuse.

Sovereign Health Group is pleased to announce the launch of a new article that's now live on the Partnership for Drug-Free Kids' website, www.drugfree.org: "The Affordable Care Act's Role in Addiction Treatment for Grown Children."

Sovereign Health has released a new article focused on the ongoing debate about Probuphine, a subdermal implant for the treatment of opioid addiction. As noted in the piece, "Political debate leaves opioid implant hanging in the balance," Braeburn Pharmaceuticals – the creator of Probuphine – announced that it's still moving forward and investing $20 million to plant a research and development manufacturing site in Durham, North Carolina.

Sovereign Health is pleased to announce the launch of a new article that's now live on www.psychologytoday.com: "Land of the Free and Depressed: A look at the cost of depression in America." The article, written by Ralph Ryback, M.D. and Kristen Fuller, M.D., focuses on depression in the United States and how a growing number of Americans measure success by the things they own as opposed to their relationships, resulting with dissatisfaction in their lives.

Sovereign Health announces the launch of a new three-part editorial series focused on Probhuphine, an opioid subdermal implant for the treatment of opioid addiction. The inaugural article in this series takes an in-depth look at the use of the implant to treat opioid dependency; this is followed by part two, taking a look at the Food and Drug Administration's (FDA) postponement on its decision to approve the implant. Amid the changing of the guard from the current Food and Drug commissioner to President Obama's nomination, Robert Califf, M.D., the FDA halted its decision on approving the use of Probuphine, also known by its generic name, buprenorphine.

This new series covers behavioral health topics relating to the United States presidential election and the current political landscape, running through Election Day, Tuesday, November 8, 2016. This latest editorial piece, "A timeline of changing attitudes toward addiction and treatment," takes a look at where popular support used to lie on addiction and how attitudes toward addiction have changed over the last 100+ years.

Sovereign Health of San Diego has opened its doors to a new eating disorders program. Specializing in the treatment of anorexia nervosa and bulimia, Sovereign Health of San Diego provides both inpatient and outpatient services for adolescent girls 12-17 years of age. Sovereign's eating disorders program offers each patient an individualized plan, encompassing Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and neurofeedback.

Sovereign Health Group is pleased to announce the launch of a new article that's now live on www.psychologytoday.com:  "The Brain's Delicate Chemistry: What do sex addiction, self-harm and runner's high all have in common?" This article, written by Ralph Ryback, M.D., Kristen Fuller, M.D. and Courtney Lopresti, M.S., focuses on how chemicals in the brain communicate with other molecules that dictate neuroses and personality and how, when these chemicals go awry, the human brain changes. To read the full article, click HERE.

Sovereign Health Group announces the launch of a major editorial campaign, "The State of Addiction Policy." This new series, which covers behavioral health topics relating to the United States presidential election and the current political landscape, will run through Election Day, Tuesday, November 8, 2016. "The State of Addiction Policy" series encompasses multiplatform coverage, including investigative reporting, educational articles, infographics and interactive elements to both inform and engage the nation's readership on the issues.

Sovereign Health Group will soon open its doors to a new eating disorders program at its Rancho San Diego facility. The eating disorders program, which is slated to open later this month, will specialize in the treatment of anorexia nervosa and bulimia, providing both inpatient and outpatient services for adolescent girls 12-17 years of age. The eating disorders program will offer each patient an individualized plan, encompassing Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), and neurofeedback.